These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1085945)

  • 41. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 42. Serum enzymatic changes in patients with schistosomiasis treated with oxamniquine or hycanthone. Comparative study.
    Saéz-Alquézar A; Ohtsuki N; Sette Júnior H; Magnanelli AC; Raia S; da Silva LC
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):105-10, 225-31. PubMed ID: 7455503
    [No Abstract]   [Full Text] [Related]  

  • 43. [Reinfection of patients in endemic areas of schistosomiasis mansoni after specific treatment. IV--Observations in Belo Horizonte].
    de Lima e Costa MF; Katz N; Dias JC
    Rev Inst Med Trop Sao Paulo; 1980; 22(3):97-107. PubMed ID: 7466152
    [No Abstract]   [Full Text] [Related]  

  • 44. Fatal hepatic necrosis in association with hycanthone.
    Hatchuel W
    S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319
    [No Abstract]   [Full Text] [Related]  

  • 45. Hycanthone: a review of its experimental chemotherapy, pharmacology and toxicology.
    Farah A; Berberian DA; Davison C; Dennis EW; Donikian MA; Drobeck HP; Ferrari RA; Yarinsky A
    Egypt J Bilharz; 1974; 1(2):181-95. PubMed ID: 4220100
    [No Abstract]   [Full Text] [Related]  

  • 46. Curative chemotherapy and resistance to reinfection in murine schistosomiasis.
    Andrade ZA; Azevedo de Brito P
    Am J Trop Med Hyg; 1982 Jan; 31(1):116-21. PubMed ID: 7058973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical studies on beta-glucuronidase enzyme in liver and spleen homogenates of normal and Schistosoma mansoni infected mice treated with hycanthone.
    Saad AA; el-Zoghby SM; el-Sewedy SM; Girgis LH; Farag HF; Moghazy M
    Biochem Pharmacol; 1978 Feb; 27(4):473-4. PubMed ID: 629806
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of repeated targeted mass treatment on the prevalence of schistosomiasis mansoni and the intensity of infection in Machakos, Kenya.
    Ouma JH; Wijers DJ; Arap Siongok TK
    Ann Trop Med Parasitol; 1985 Aug; 79(4):431-8. PubMed ID: 3935065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of oral and parenteral activity of hycanthone and lucanthone in experimental infections with Schistosoma mansoni.
    Berberian DA; Freele H; Rosi D; Dennis EW; Archer S
    Am J Trop Med Hyg; 1967 Jul; 16(4):487-91. PubMed ID: 5006468
    [No Abstract]   [Full Text] [Related]  

  • 50. Two-year follow-up of hycanthone-treated schistosomiasis mansoni patients in St. Lucia.
    Cook JA; Woodstock L; Jordan P
    Am J Trop Med Hyg; 1974 Sep; 23(5):910-4. PubMed ID: 4451231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
    Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
    Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
    [No Abstract]   [Full Text] [Related]  

  • 52. Re-infection of patients in schistosomiasis mansoni endemic areas after specific treatment. I--influence of age and worm burden.
    Katz N; Zicker F; Rocha RS; Oliveira VB
    Rev Inst Med Trop Sao Paulo; 1978; 20(5):273-8. PubMed ID: 725427
    [No Abstract]   [Full Text] [Related]  

  • 53. Current results in the clinical therapy of schistosomiasis mansoni.
    Katz N
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
    [No Abstract]   [Full Text] [Related]  

  • 54. [Toxic reactions with the use of hycanthone].
    Gonçalves CS; Buaiz V; Zanandréa J; Zanotti WM; Boni ES; de Castro Filho AK; Pereira FE
    AMB Rev Assoc Med Bras; 1977 Sep; 23(9):305-8. PubMed ID: 304227
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of chemotherapy on experimental pulmonary schistosomiasis.
    de Almeida MA; Andrade ZA
    Am J Trop Med Hyg; 1983 Sep; 32(5):1049-54. PubMed ID: 6625060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The epidemiology of Schistosoma mansoni infection in Tensae Berhan, Ethiopia: prevalence of schistosomiasis.
    Lemma A; DeSole G; Polderman AM; Mazengia B; Redda A; Kloos H
    Ethiop Med J; 1979 Jul; 17(3):63-74. PubMed ID: 540657
    [No Abstract]   [Full Text] [Related]  

  • 57. Hycanthone trial in the treatment of Schistosoma mansoni infection in Sudan.
    Omer AH; Abdullah EA; Elhassan AM; Wasfi AM
    J Trop Med Hyg; 1972 Sep; 75(9):165-8. PubMed ID: 5085839
    [No Abstract]   [Full Text] [Related]  

  • 58. Fatal hepatic necrosis in association with the use of hycanthone.
    Dennis EW
    S Afr Med J; 1978 Jul; 54(4):137-8. PubMed ID: 694710
    [No Abstract]   [Full Text] [Related]  

  • 59. Liver pathology in hycanthone hepatitis.
    Cohen C
    Gastroenterology; 1978 Jul; 75(1):103-6. PubMed ID: 401084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hepatopathy after treatment of schistosomiasis mansoni with hycanthone. II. Report of a case of death after 30 days of treatment].
    Godoy P; de Oliveira MC; Raso P; Marinho RP; Neves J
    Rev Inst Med Trop Sao Paulo; 1974 Mar; 16(2):114-20. PubMed ID: 4845458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.